Biopharma Business

Tag "Spain"

A Spanish Biosimilar of Amgen’s Blockbuster gets Ready for EU Approval

    A Spanish Biosimilar of Amgen’s Blockbuster gets Ready for EU Approval

Cinfa Biotech announced trial results for a biosimilar of Amgen’s Neulasta, a multi-billion blockbuster to treat chemotherapy-induced neutropenia. Cinfa Biotech is a Spanish company specialized in developing biosimilars. The biotech

Read Full Article

Final deadline to notify hazardous mixtures with Spanish poison centre

    Final deadline to notify hazardous mixtures with Spanish poison centre

Business placing products on the market in Spain must notify their products ahead of 1 June 2017 or risk enforcement by the Spanish Authorities Businesses that place mixtures with a

Read Full Article

Spanish Pharma Market Shows Signs of Stability

Spain’s pharmaceutical market set to show signs of stability, surpassing $25 billion by 2021, says GlobalData. The Spanish pharmaceutical market is set to see a slight rise in value from

Read Full Article

Physical inactivity and sedentary behaviors associated with cardiometabolic risk factors

The results are from the first investigation to be conducted with baseline data from the PREDIMED-PLUS study, an 8-year multicenter clinical trial based on a nutritional intervention involving an energy-restricted

Read Full Article

Heart of the matter: Spain’s first artificial heart transplant

A medical team from Clínica Universidad de Navarra in Pamplona has successfully performed Spain’s first implant of the SynCardia temporary Total Artificial Heart. The 47-year-old patient, was suffering from severe

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements